The history of uveitis: from antiquity to the present day

被引:0
作者
Ghadiri, Nima [1 ,2 ]
机构
[1] Liverpool Univ Hosp NHS Fdn Trust, Dept Ophthalmol, Liverpool, England
[2] Univ Liverpool, Dept Eye & Vision Sci, Liverpool, England
关键词
THERAPY; PREDNISOLONE; EYE;
D O I
10.1038/s41433-024-03519-x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
This comprehensive review traces the historical understanding and treatment of uveitis from ancient civilisations to modern medicine, a history which reflects the evolution of medical understanding and practice in general. Early descriptions of ocular inflammation appear in Egyptian medical papyri from 1700 BCE, with subsequent contributions from Greek and Roman physicians, including Hippocrates and Galen, who provided foundational observations of ocular inflammatory conditions. Medieval scholars in the Middle East, particularly Avicenna, preserved and advanced classical knowledge while recognising the systemic nature of ocular inflammation. The Renaissance and Enlightenment periods brought anatomical precision and the emergence of ophthalmology as a distinct specialty, notably through innovations such as Helmholtz's ophthalmoscope in 1851. The twentieth century marked a paradigm shift with the evolution of immunological understanding, leading to the recognition of autoimmune mechanisms and genetic predispositions in uveitis. The introduction of corticosteroids mid-century revolutionised treatment, followed by the development of steroid-sparing immunomodulatory agents and, more recently, targeted biological therapies. Contemporary advances in imaging technology and the establishment of international collaborative groups have standardised classification and treatment approaches. This historical perspective demonstrates the progression from empirical observations to precision medicine in uveitis, highlighting the importance of understanding this evolution for advancing future therapeutic strategies.
引用
收藏
页码:488 / 491
页数:4
相关论文
共 40 条
  • [1] ANDRASCH RH, 1978, ARCH OPHTHALMOL-CHIC, V96, P247
  • [2] Anonymous, 2005, International Ophthalmology Clinics, V45, P1, DOI 10.1097/01.iio.0000155938.83083.94
  • [3] Avicenna A, 1988, GHANOON DAR TEB, P244
  • [4] Barow ME., 1934, BIOS, V5, P157
  • [5] Breasted JH., 1930, E SMITH SURG PAPYRUS
  • [6] ACUTE ANTERIOR UVEITIS AND HL-A 27
    BREWERTON, DA
    NICHOLLS, A
    CAFFREY, M
    WALTERS, D
    [J]. LANCET, 1973, 2 (7836) : 994 - 996
  • [7] CYCLOPHOSPHAMIDE THERAPY OF PERIPHERAL UVEITIS
    BUCKLEY, CE
    GILLS, JP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1969, 124 (01) : 29 - &
  • [8] HLA-B51 MAY SERVE AS AN IMMUNOGENETIC MARKER FOR A SUBGROUP OF PATIENTS WITH BEHCETS-SYNDROME
    CHAJEKSHAUL, T
    PISANTY, S
    KNOBLER, H
    MATZNER, Y
    GLICK, M
    RON, N
    ROSENMAN, E
    BRAUTBAR, C
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 83 (04) : 666 - 672
  • [9] DAVIS JL, 1990, OPHTHALMOLOGY, V97, P1137
  • [10] The eye of Vesalius
    De Laey, Jean J.
    [J]. ACTA OPHTHALMOLOGICA, 2011, 89 (03) : 293 - 300